News
Ad hoc announcement pursuant to Art. 53 LR News Release
AEVIS VICTORIA SA (AEVS.SW) – Continued revenue growth in the third quarter of 2025
Here's Why Avidity Biosciences Stock Soared This Week (There's More to the Deal Than You Might Think)
Shares in Avidity Biosciences (NASDAQ: RNA) soared by 42% in the week to Friday morning following the announcement of a unanimous deal for Avidity to be acquired by Novartis (NYSE: NVS) for $72 per
Julius Baer to set up new branch in Portugal
Why Dyne Therapeutics Stock Crushed the Market on Monday
Dyne Therapeutics (NASDAQ: DYN) had a Monday neither it nor its investors will ever forget. This wasn't of its own making, however, as a premium-priced buyout of a peer was attracting serious
Why Avidity Biosciences Stock Blasted 42% Higher Today
A richly priced buyout seriously boosted the share price of biotech Avidity Biosciences (NASDAQ: RNA) as the stock trading week began. The company's equity rose by 42%, closing to land just below
Strong profitable growth continues
Why STMicroelectronics Stock Plummeted Today
STMicroelectronics (NYSE: STM) stock suffered a big sell-off in Thursday's trading. The company's share price closed out the day's session down 13.1%, despite the S&P 500 (SNPINDEX: ^GSPC) climbing
Silver economy ushers in a new era of growth for life insurance
Holcim to acquire Xella
Q3 2025 results
Watch Out Eli Lilly, This Pharma Giant Is Gunning to Be a Top Player in the Obesity Market
Eli Lilly (NYSE: LLY) is the most valuable healthcare stock in the world, with a market capitalization of more than $760 billion. It has been soaring in recent years due to the success of its highly
ABB to divest Robotics division to SoftBank Group
2 Surefire Dividend Stocks to Buy for the Long Haul
Equity markets experienced significant volatility this year. Many investors feared that President Donald Trump's aggressive trade policies would plunge the economy into a recession and lead to a
AEVIS VICTORIA SA – Strong growth in revenue in the first half of 2025. Free cash flow exceeds CHF 100 million, enabling debt reduction of more than CHF 120 million.
GLP-1 drugs may reduce mortality by up to 6.4% in the US by 2045
NAGRAVISION and MediaTek Reinvent Streaming Security with Next-Gen DRM Protection
NAGRAVISION Launches OpenTV® ENTera, the Next-Generation Digital Services Solution, in AWS Marketplace
NAGRAVISION Extends OneTV Solution at ONE Hungary, powered by OpenTV® ENTera to enable Third-Party Service Bundling with the Digital Vending Machine® from Bango
Holistic approach needed to maintain resilience in a complex risk landscape
AEVIS VICTORIA SA – Strong growth in revenue and consolidated results in the first half of 2025
Global property and casualty insurance market has increased efficiency, capacity and resilience, finds Swiss Re Institute
Why Shares in Arrowhead Pharmaceuticals Surged on News of a Novartis Deal
Shares in Arrowhead Pharmaceuticals (NASDAQ: ARWR) rose by more than 27% in the week to Friday morning. The company's bold aim is to have "20 individual products, either partnered or wholly owned
AEVIS VICTORIA SA (AEVS.SW) – Swiss Medical Network – Revenue increased by more than 20% in the first half of 2025 despite challenging conditions



